681 related articles for article (PubMed ID: 3126228)
1. Potentiation of lymphokine-induced macrophage activation by tumor necrosis factor-alpha.
Heidenreich S; Weyers M; Gong JH; Sprenger H; Nain M; Gemsa D
J Immunol; 1988 Mar; 140(5):1511-8. PubMed ID: 3126228
[TBL] [Abstract][Full Text] [Related]
2. Tumor target-derived soluble factor synergizes with IFN-gamma and IL-2 to activate macrophages for tumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target.
Jiang H; Stewart CA; Fast DJ; Leu RW
J Immunol; 1992 Sep; 149(6):2137-46. PubMed ID: 1517576
[TBL] [Abstract][Full Text] [Related]
3. The induction and augmentation of macrophage tumoricidal responses by platelet-activating factor.
Howard AD; Erickson KL
Cell Immunol; 1995 Aug; 164(1):105-12. PubMed ID: 7634340
[TBL] [Abstract][Full Text] [Related]
4. Production of tumor necrosis factor by rIFN-gamma-primed C3H/HeJ (Lpsd) macrophages requires the presence of lipid A-associated proteins.
Hogan MM; Vogel SN
J Immunol; 1988 Dec; 141(12):4196-202. PubMed ID: 3143760
[TBL] [Abstract][Full Text] [Related]
5. Macrophage activation by granulocyte/macrophage colony-stimulating factor. Priming for enhanced release of tumor necrosis factor-alpha and prostaglandin E2.
Heidenreich S; Gong JH; Schmidt A; Nain M; Gemsa D
J Immunol; 1989 Aug; 143(4):1198-205. PubMed ID: 2473121
[TBL] [Abstract][Full Text] [Related]
6. Effect of recombinant tumor necrosis factor on tumoricidal activation of murine macrophages: synergism between tumor necrosis factor and gamma-interferon.
Hori K; Ehrke MJ; Mace K; Mihich E
Cancer Res; 1987 Nov; 47(22):5868-74. PubMed ID: 3117358
[TBL] [Abstract][Full Text] [Related]
7. Poly I:C activated macrophages are tumoricidal for TNF-alpha-resistant 3LL tumor cells.
Remels L; Fransen L; Huygen K; De Baetselier P
J Immunol; 1990 Jun; 144(11):4477-86. PubMed ID: 2111350
[TBL] [Abstract][Full Text] [Related]
8. Role of tumor necrosis factor and interleukin 1 in gamma-interferon-promoted activation of mouse tumoricidal macrophages.
Hori K; Mihich E; Ehrke MJ
Cancer Res; 1989 May; 49(10):2606-14. PubMed ID: 2496917
[TBL] [Abstract][Full Text] [Related]
9. Interferon-gamma synergizes with tumor necrosis factor and with interleukin 1 and requires the presence of both monokines to induce antitumor cytotoxic activity in macrophages.
Chen L; Suzuki Y; Wheelock EF
J Immunol; 1987 Dec; 139(12):4096-101. PubMed ID: 3121728
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic differences between migration inhibitory factor (MIF) and IFN-gamma for macrophage activation. MIF and IFN-gamma synergize with lipid A to mediate migration inhibition but only IFN-gamma induces production of TNF-alpha and nitric oxide.
Herriott MJ; Jiang H; Stewart CA; Fast DJ; Leu RW
J Immunol; 1993 May; 150(10):4524-31. PubMed ID: 7683323
[TBL] [Abstract][Full Text] [Related]
11. Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha.
Green SJ; Crawford RM; Hockmeyer JT; Meltzer MS; Nacy CA
J Immunol; 1990 Dec; 145(12):4290-7. PubMed ID: 2124240
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta 1 primes macrophages for enhanced expression of the nitric oxide synthase gene for nitric oxide-dependent cytotoxicity against Entamoeba histolytica.
Lin JY; Seguin R; Keller K; Chadee K
Immunology; 1995 Jul; 85(3):400-7. PubMed ID: 7558128
[TBL] [Abstract][Full Text] [Related]
13. Identification of a unique T cell-derived lymphokine that primes macrophages for tumor cytotoxicity.
Kern DE; Grabstein KH; Okuno K; Schreiber RD; Greenberg PD
J Immunol; 1989 Dec; 143(12):4308-16. PubMed ID: 2687379
[TBL] [Abstract][Full Text] [Related]
14. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production.
Ding AH; Nathan CF; Stuehr DJ
J Immunol; 1988 Oct; 141(7):2407-12. PubMed ID: 3139757
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-alpha triggers antitoxoplasmal activity of IFN-gamma primed macrophages.
Sibley LD; Adams LB; Fukutomi Y; Krahenbuhl JL
J Immunol; 1991 Oct; 147(7):2340-5. PubMed ID: 1918966
[TBL] [Abstract][Full Text] [Related]
16. The glycosyl-inositol-phosphate and dimyristoylglycerol moieties of the glycosylphosphatidylinositol anchor of the trypanosome variant-specific surface glycoprotein are distinct macrophage-activating factors.
Magez S; Stijlemans B; Radwanska M; Pays E; Ferguson MA; De Baetselier P
J Immunol; 1998 Feb; 160(4):1949-56. PubMed ID: 9469458
[TBL] [Abstract][Full Text] [Related]
17. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2.
Alleva DG; Burger CJ; Elgert KD
J Immunol; 1994 Aug; 153(4):1674-86. PubMed ID: 8046239
[TBL] [Abstract][Full Text] [Related]
18. Cytolytic mechanisms of activated macrophages. Tumor necrosis factor and L-arginine-dependent mechanisms act synergistically as the major cytolytic mechanisms of activated macrophages.
Higuchi M; Higashi N; Taki H; Osawa T
J Immunol; 1990 Feb; 144(4):1425-31. PubMed ID: 2303713
[TBL] [Abstract][Full Text] [Related]
19. [Activation of macrophages with Hochu-ekkito].
Kataoka T; Akagawa KS; Tokunaga T; Nagao S
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1490-3. PubMed ID: 2499265
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte-macrophage colony-stimulating factor and IFN-gamma restore the systemic TNF-alpha response to endotoxin in lipopolysaccharide-desensitized mice.
Bundschuh DS; Barsig J; Hartung T; Randow F; Döcke WD; Volk HD; Wendel A
J Immunol; 1997 Mar; 158(6):2862-71. PubMed ID: 9058823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
